抗新冠口服药生产商真实生物向港交所提交上市申请书

华尔街见闻2022-08-04

据港交所文件：真实生物科技有限公司向港交所提交上市申请书。保荐机构为中金公司。真实生物的核心产品阿兹夫定为具有广谱抗病毒活性的创新药物，已分别于2021年7月及2022年7月获国家药监局附条件批准用于治疗HIV感染及COVID-19，为中国公司研发的首个获国家药监局批准用于治疗COVID-19的口服直接抗病毒药物。公司已做好充分准备以启动阿兹夫定的商业销售。真实生物在文件中披露，已与中国多家领先...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Youn7276
2022-08-05
Youn7276
Ok

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160989938?lang=en_US&edition=fundamental","thumbnail":"https://static.tigerbbs.com/9da5a07e39259fa2f511a16e6b7f95df","is_english":false,"pubTime":"2022-08-04 23:08","share_image_url":"https://static.laohu8.com/cc96873d3d23ee6ac10685520df9c100","id":"1160989938","market":"hk","top_or_hot":-1,"title":"抗新冠口服药生产商真实生物向港交所提交上市申请书","media":"华尔街见闻","content":"<div>\n<p>据港交所文件：真实生物科技有限公司向港交所提交上市申请书。保荐机构为中金公司。真实生物的核心产品阿兹夫定为具有广谱抗病毒活性的创新药物，已分别于2021年7月及2022年7月获国家药监局附条件批准用于治疗HIV感染及COVID-19，为中国公司研发的首个获国家药监局批准用于治疗COVID-19的口服直接抗病毒药物。公司已做好充分准备以启动阿兹夫定的商业销售。真实生物在文件中披露，已与中国多家领先...</p>\n\n<a href=\"https://wallstreetcn.com/livenews/2234686\">Source Link</a>\n\n</div>\n","source":"highlight_wallstreetcn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>抗新冠口服药生产商真实生物向港交所提交上市申请书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n抗新冠口服药生产商真实生物向港交所提交上市申请书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-04 23:08 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/livenews/2234686><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>据港交所文件：真实生物科技有限公司向港交所提交上市申请书。保荐机构为中金公司。真实生物的核心产品阿兹夫定为具有广谱抗病毒活性的创新药物，已分别于2021年7月及2022年7月获国家药监局附条件批准用于治疗HIV感染及COVID-19，为中国公司研发的首个获国家药监局批准用于治疗COVID-19的口服直接抗病毒药物。公司已做好充分准备以启动阿兹夫定的商业销售。真实生物在文件中披露，已与中国多家领先...</p>\n\n<a href=\"https://wallstreetcn.com/livenews/2234686\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159718","symbol_name":"港股医药","start_time":0,"source_url":"https://wallstreetcn.com/livenews/2234686","article_id":"1160989938","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/9da5a07e39259fa2f511a16e6b7f95df"],"rights":{"source":"highlight_wallstreetcn","url":"https://wallstreetcn.com/livenews/2234686","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1160989938","pubTimestamp":1659625717,"sourceInfo":{"source_id":"highlight_wallstreetcn","name":"华尔街见闻"},"weMediaInfo":null,"summary":"真实生物的核心产品阿兹夫定为具有广谱抗病毒活性的创新药物。","collect":0,"end_time":0,"defaultTopTitle":"wallstreetcn.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159718":"港股医药"},"translate_title":"Real Bio, a manufacturer of anti-COVID-19 oral drugs, submitted an application for listing to the Hong Kong Stock Exchange","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/135e271bc482501bbe5562db7d4f7bc7","symbols_score_info":{"159718":0.9},"content_text":"据港交所文件：真实生物科技有限公司向港交所提交上市申请书。保荐机构为中金公司。真实生物的核心产品阿兹夫定为具有广谱抗病毒活性的创新药物，已分别于2021年7月及2022年7月获国家药监局附条件批准用于治疗HIV感染及COVID-19，为中国公司研发的首个获国家药监局批准用于治疗COVID-19的口服直接抗病毒药物。公司已做好充分准备以启动阿兹夫定的商业销售。真实生物在文件中披露，已与中国多家领先药品制造商（包括北京协和）订立战略协议，为公司生产及供应阿兹夫定的活性药物成分（API）及片剂。公司亦具备自行生产能力，年产能约为十亿片剂阿兹夫定。公司认为，基于自有及合约产能的结合将能够生产足够数量的阿兹夫定以满足市场需求。","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":9902971699,"gmtCreate":1659650314013,"gmtModify":1705586635706,"author":{"id":"3577393549070429","authorId":"3577393549070429","name":"Youn7276","avatar":"https://static.tigerbbs.com/487c5c26a5e210d6b88adaeaba12329b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577393549070429","authorIdStr":"3577393549070429"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902971699","repostId":1160989938,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":50,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160989938"}